Focused Issue on Anticoagulation, Catheterization, and Minimizing Intervention: How Cutting-Edge Cuts Down Disease

Posted On 2019-06-22 15:25:39

This focused issue on “Anticoagulation, Catheterization, and Minimizing Intervention: How Cutting-Edge Cuts Down Disease” is edited by Dr. Rami Khouzam, Professor of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.

Dr. Khouzam is a practicing Interventional Cardiologist in Germantown, TN. Dr. Khouzam graduated from Ain Shams University Faculty of Medicine in 1994 and has been in practice for 25 years. He completed a residency at Tucson Hospitals Medical Education Program Inc. He currently practices at Specialty Physician Group LLC and is affiliated with Baptist Memorial Hospital Tipton. Dr. Khouzam accepts multiple insurance plans including Aetna, Humana, and Medicare. Dr. Khouzam also practices at Methodist Healthcare -Memphis Hospitals in Memphis, TN.

Focused issue outline:

  1. The Death of Aspirin for Primary Prevention of Acute Coronary Syndrome
  2. A Review of Aspirin in Obesity
  3. From WOEST (2013) to AUGUSTUS (2019) Part 1: Dual vs. Triple Therapy in Acute Coronary Syndrome Patients with Atrial Fibrillation
  4. From WOEST (2013) to AUGUSTUS (2019) Part 2: Potent P2Y12 Inhibitors as Part of Dual vs. Triple Therapy for Percutaneous Coronary Intervention in Atrial Fibrillation Patients
  5. Atrial Fibrillation in the Post-Operative Setting: Should we Anticoagulate?
  6. Intravenous Cangrelor as a Peri-Procedural Bridge
  7. Potent P2Y12 Inhibitors: Do they increase cancer risk?
  8. The Reversal of Ticagrelor: A Review
  9. Reversal strategies of DOACs: Where are we? Where are we going?
  10. Is early invasive management as STEMI warranted in De Winter’s sign? A “peak” into the widow-maker
  11. After COACT: New guidelines for NSTEMI management
  12. Identifying common barriers to cardiac rehabilitation: A Review of the Literature
  13. Cardiac Rehab: An Action Plan
  14. Apple Watch/Rhythm: Where Are We?
  15. LifeVest: Dead on Arrival or Chance of Survival?
  16. CardioMEMS in Pulmonary Hypertension
  17. Is there an optimal door-to-EKOS time?
  18. Transcarotid transcatheter aortic valve replacement: A review of the current literature
  19. Accuracy of non-invasive hemodynamic monitoring in the ICU: Where do we stand?
  20. The renal resistive index as a new complementary tool to predict microvascular diabetic complications in children and adolescents: A groundbreaking finding